Significant drug interactions with lamotrigine are summarized in Table 13. Additional details of these drug interaction studies are provided in the Clinical Pharmacology subsection [see Clinical Pharmacology].
Table 13. Established and Other Potentially Significant Drug Interactions
Concomitant Drug
Effect on Concentration of Lamotrigine or Concomitant Drug
Clinical Comment
Estrogen-containing oral contraceptive preparation containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel
↓ lamotrigine
Decreased lamotrigine levels approximately 50%.
↓ levonorgestrel
Decrease in levonorgestrel component by 19%.
Carbamazepine (CBZ) and CBZ epoxide
↓ lamotrigine
Addition of carbamazepine decreases lamotrigine concentration approximately 40%.
? CBZ epoxide
May increase CBZ epoxide levels
Phenobarbital/Primidone
↓ lamotrigine
Decreased lamotrigine concentration approximately 40%.
Phenytoin (PHT)
↓ lamotrigine
Decreased lamotrigine concentration approximately 40%.
Rifampin
↓ lamotrigine
Decreased lamotrigine AUC approximately 40%.
Valproate
↑ lamotrigine
Increased lamotrigine concentrations slightly more than 2-fold.
? valproate
Decreased valproate concentrations an average of 25% over a 3-week period then stabilized in healthy volunteers; no change in controlled clinical trials in epilepsy patients.
Overdoses involving quantities up to 15 g have been reported for LAMICTAL, some of which have been fatal. Overdose has resulted in ataxia, nystagmus, increased seizures, decreased level of consciousness, coma, and intraventricular conduction delay.
Management of Overdose
There are no specific antidotes for lamotrigine. Following a suspected overdose, hospitalization of the patient is advised. General supportive care is indicated, including frequent monitoring of vital signs and close observation of the patient. If indicated, emesis should be induced or gastric lavage should be performed; usual precautions should be taken to protect the airway. It should be kept in mind that lamotrigine is rapidly absorbed [see Clinical Pharmacology]. It is uncertain whether hemodialysis is an effective means of removing lamotrigine from the blood. In 6 renal failure patients, about 20% of the amount of lamotrigine in the body was removed by hemodialysis during a 4-hour session. A Poison Control Center should be contacted for information on the management of overdosage of LAMICTAL.
CONTRAINDICATIONS
LAMICTAL is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients [see Boxed Warning].